BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23743310)

  • 1. Changes in QuantiFERON®-TB Gold In-Tube results during treatment for tuberculous infection.
    Bastos ML; Menzies D; Belo MT; Teixeira EG; de Abreu ST; Antas PR; Trajman A
    Int J Tuberc Lung Dis; 2013 Jul; 17(7):909-16. PubMed ID: 23743310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serial interferon-gamma release assays after rifampicin prophylaxis in a tuberculosis outbreak.
    Lee SH; Lew WJ; Kim HJ; Lee HK; Lee YM; Cho CH; Lee EJ; Lee DY; Ryu SW; Oh SY; Kim SO; Shim TS
    Respir Med; 2010 Mar; 104(3):448-53. PubMed ID: 19879123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of latent tuberculosis infection before initiation of anti-tumor necrosis factor therapy using both tuberculin skin test and QuantiFERON-TB Gold In Tube assay.
    Kim HC; Jo KW; Jung YJ; Yoo B; Lee CK; Kim YG; Yang SK; Byeon JS; Kim KJ; Ye BD; Shim TS
    Scand J Infect Dis; 2014 Nov; 46(11):763-9. PubMed ID: 25195652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Latent tuberculosis infection treatment for prison inmates: a randomised controlled trial.
    Chan PC; Yang CH; Chang LY; Wang KF; Lu BY; Lu CY; Shao PL; Hsueh PR; Fang CT; Huang LM
    Int J Tuberc Lung Dis; 2012 May; 16(5):633-8. PubMed ID: 22410137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective cohort study of latent tuberculosis in adult close contacts of active pulmonary tuberculosis patients in Korea.
    Park SH; Lee SJ; Cho YJ; Jeong YY; Kim HC; Lee JD; Kim HJ; Menzies D
    Korean J Intern Med; 2016 May; 31(3):517-24. PubMed ID: 27052266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and follow-up of treatment of latent tuberculosis; the utility of the QuantiFERON-TB Gold In-tube assay in outpatients from a tuberculosis low-endemic country.
    Dyrhol-Riise AM; Gran G; Wentzel-Larsen T; Blomberg B; Haanshuus CG; Mørkve O
    BMC Infect Dis; 2010 Mar; 10():57. PubMed ID: 20210999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic changes of interferon gamma release assay results with latent tuberculosis infection treatment.
    Xin H; Cao X; Zhang H; Liu J; Pan S; Li X; Guan L; Shen F; Liu Z; Wang D; Guan X; Yan J; Li H; Feng B; Zhang M; Yang Q; Jin Q; Gao L;
    Clin Microbiol Infect; 2020 Nov; 26(11):1555.e1-1555.e7. PubMed ID: 32062048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection and management of latent tuberculosis in liver transplant patients.
    Jafri SM; Singal AG; Kaul D; Fontana RJ
    Liver Transpl; 2011 Mar; 17(3):306-14. PubMed ID: 21384513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycobacterial interferon-γ release variations during longterm treatment with tumor necrosis factor blockers: lack of correlation with clinical outcome.
    Scrivo R; Sauzullo I; Mengoni F; Priori R; Coppola M; Iaiani G; DI Franco M; Vullo V; Mastroianni CM; Valesini G
    J Rheumatol; 2013 Feb; 40(2):157-65. PubMed ID: 23204217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases.
    Bartalesi F; Vicidomini S; Goletti D; Fiorelli C; Fiori G; Melchiorre D; Tortoli E; Mantella A; Benucci M; Girardi E; Cerinic MM; Bartoloni A
    Eur Respir J; 2009 Mar; 33(3):586-93. PubMed ID: 19047313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with treatment adherence in a randomised trial of latent tuberculosis infection treatment.
    Trajman A; Long R; Zylberberg D; Dion MJ; Al-Otaibi B; Menzies D
    Int J Tuberc Lung Dis; 2010 May; 14(5):551-9. PubMed ID: 20392347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QuantiFERON-TB Gold In-Tube test (QFT-GIT) for the screening of latent tuberculosis in recent immigrants to Italy.
    Saracino A; Scotto G; Fornabaio C; Martinelli D; Faleo G; Cibelli D; Tartaglia A; Di Tullio R; Fazio V; Prato R; Monno L; Angarano G
    New Microbiol; 2009 Oct; 32(4):369-76. PubMed ID: 20128443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of latent tuberculosis infection with short-course regimens in potential living kidney donors.
    Simkins J; Donato-Santana C; Morris MI; Abbo LM; Camargo JF; Anjan S; Natori Y; Guerra G
    Transpl Infect Dis; 2020 Apr; 22(2):e13244. PubMed ID: 31923346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QuantiFERON-TB Gold In-Tube test conversions and reversions among tuberculosis patients and their household contacts in Addis Ababa: a one year follow-up study.
    Belay M; Legesse M; Dagne D; Mihret A; Bekele Y; Medhin G; Bjune G; Abebe F
    BMC Infect Dis; 2014 Dec; 14():654. PubMed ID: 25466365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of rituximab therapy on released interferon-γ levels in the QuantiFERON assay among RA patients with different status of Mycobacterium tuberculosis infection.
    Chen YM; Chen HH; Lai KL; Hung WT; Lan JL; Chen DY
    Rheumatology (Oxford); 2013 Apr; 52(4):697-704. PubMed ID: 23264552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A positive test QuantiFERON-TB Gold In-Tube in a patient treated with continuous ambulatory peritoneal dialysis].
    Niepolski L; Grzegorzewska AE
    Pol Merkur Lekarski; 2014 Dec; 37(222):341-3. PubMed ID: 25715574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection prior to hematopoietic stem cell transplantation.
    Moon SM; Lee SO; Choi SH; Kim YS; Woo JH; Yoon DH; Suh C; Kim DY; Lee JH; Lee JH; Lee KH; Kim SH
    Transpl Infect Dis; 2013 Feb; 15(1):104-9. PubMed ID: 22823749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of prophylaxis on QuantiFERON TB-2G responses among children].
    Higuchi K; Okada K; Harada N; Mori T
    Kekkaku; 2008 Sep; 83(9):603-9. PubMed ID: 18979994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in diagnostic methods and treatment of latent tuberculosis infection in a tertiary care center from 2000 to 2017.
    Uzorka JW; Duinkerk DL; Kroft LJM; Bakker JA; Ramai RSRS; Ottenhoff THM; Arend SM
    Eur J Clin Microbiol Infect Dis; 2020 Jul; 39(7):1329-1337. PubMed ID: 32076881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventive tuberculosis treatment effect on QuantiFERON TB-Gold in-tube testing in a high tuberculosis-endemic country: A clinical trial.
    Yang Q; Ruan Q; Liu X; Shen Y; Jiang T; Wu J; Cai L; Pan K; Lin M; Huang X; Shao L; Zhang W
    Int J Infect Dis; 2020 Feb; 91():182-187. PubMed ID: 31770617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.